Stericycle, Inc.

NASDAQ:SRCL

61.98 (USD) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995
Revenue 2,659.32,704.72,646.92,675.53,308.93,485.93,580.73,562.3422,985.9082,555.6012,142.8071,913.1491,676.0481,439.3881,177.7361,083.679932.767789.637609.457516.228453.225401.519359.024323.722132.866.746.224.521.3
Cost of Revenue 1,750.91,679.11,629.71,622.42,134.42,109.92,118.22,059.131,779.3741,461.191,178.1731,055.844915.304771.961625.34598.65514.846439.77341.42288.022256.6237.01215.959172.87676.241.23117.315.6
Gross Profit 908.41,025.61,017.21,053.11,174.51,3761,462.51,503.2121,206.5341,094.411964.634857.305760.744667.427552.396485.029417.921349.867268.037228.206196.625164.509143.065150.84656.625.515.27.25.7
Gross Profit Ratio 0.3420.3790.3840.3940.3550.3950.4080.4220.4040.4280.450.4480.4540.4640.4690.4480.4480.4430.440.4420.4340.410.3980.4660.4260.3820.3290.2940.268
Reseach & Development Expenses 00000000000000000000000000000
General & Administrative Expenses 000001,178.41,470.1904.179712.803489.937390.61356.817311.522262.357227.873208.805176.737144.36698.03280.62369.55860.40266.08659.45726.514.910.77.60
Selling & Marketing Expenses 0000000125.218-172.859-56.072-18.519-29.686-19.7456.044-5.39-9.6340000000000000
SG&A 707.1887.5946.6897.61,055.11,178.41,470.11,029.397539.944433.865372.091327.131291.777268.401222.483199.171176.737144.36698.03280.62369.55860.40266.08659.45726.514.910.77.68.1
Other Expenses -0.10.70.3-6-9.5-8.3-6.6-7.5860.569-2.746-2.924-0.36966.04613.90510.0387.5815.3350.31.651.1550.672.9133.68523.4699.94.13.12.11.9
Operating Expenses 707.1887.5946.6897.61,055.11,178.41,470.11,064.149605.714482.003410.496358.783316.688275.365227.873203.682192.072144.66699.68281.77869.55863.31569.77182.92636.41913.89.710
Operating Income 201.3153.772.3149.5109.9-161.1-7.6439.063487.612556.336535.619468.836424.311370.683315.189274.239224.544201.762168.355145.655126.397100.83273.29467.9220.26.51.4-2.5-4.3
Operating Income Ratio 0.0760.0570.0270.0560.033-0.046-0.0020.1230.1630.2180.250.2450.2530.2580.2680.2530.2410.2560.2760.2820.2790.2510.2040.210.1520.0970.03-0.102-0.202
Total Other Income Expenses Net -198-74.8-71.6-205.5-472.7-367-6.6-7.586-112.639-58.818-21.443-30.055-23.1-23.394-12.703-2.589-17.569-5.866-45.778-8.391-6.04-4.509-1.851-4.877-7.40.70.60.40
Income Before Tax 3.378.90.7-56-362.8-275.4-107.9333.768410.907487.568477.746417.197372.324331.853277.688239.004191.24172.574111.98128.564108.72975.57736.74823.8167.86.31.5-2.10
Income Before Tax Ratio 0.0010.0290-0.021-0.11-0.079-0.030.0940.1380.1910.2230.2180.2220.2310.2360.2210.2050.2190.1840.2490.240.1880.1020.0740.0590.0940.032-0.0860
Income Tax Expense 24.622.427.5-0.1-16.8-29.8-150.9126.259142.862159.422164.662147.256134.981121.396101.29990.29672.86267.30444.82650.38642.94829.85314.7299.305-6.20.60.1-0.10.2
Net Income -21.456-26.8-55.9-346-244.742.4205.969267.078326.456311.372267.996234.751207.879175.691148.708118.378105.2767.15478.17865.78145.72414.7114.511145.71.4-2.4-4.5
Net Income Ratio -0.0080.021-0.01-0.021-0.105-0.070.0120.0580.0890.1280.1450.140.140.1440.1490.1370.1270.1330.110.1510.1450.1140.0410.0450.1050.0850.03-0.098-0.211
EPS -0.230.61-0.29-0.61-3.8-2.810.272.093.013.853.643.122.772.392.031.741.351.190.760.890.80.560.190.20.240.140.035-0.08-0.2
EPS Diluted -0.230.61-0.29-0.61-3.8-2.810.272.082.963.793.563.082.692.392.031.681.321.160.740.850.720.510.180.180.230.130.033-0.08-0.2
EBITDA 417.8371.3294.8383382.7445.2235.3684.075728.801714.278639.622574.84510.901446.213364.826308.845274.555238.103235.564176.622150.362120.684100.37996.26637.59.93.9-0.8-2.4
EBITDA Ratio 0.1570.1370.1110.1430.1160.1280.0660.1920.2440.2790.2980.30.3050.310.310.2850.2940.3020.3870.3420.3320.3010.280.2970.2820.1480.084-0.033-0.113